Scientists explore how the immune and nervous systems constantly communicate, influencing brain diseases, behavior, and ...

Researchers at The University of Texas MD Anderson Cancer Center have identified a potential breakthrough in the fight ...

People with early-onset Parkinson’s face challenges different from those with traditional late-onset Parkinson’s.

The discovery and development of GLP-1 receptor agonists for type 2 diabetes and obesity is a bench-to-bedside success story.1 Multiple GLP-1 receptor agonists are now in clinical use, such as ...

Researchers from the University College Cork have described the neuroprotective effect of TMP-269, a class-IIa-specific histone deacetylase (HDAC) inhibitor in preclinical models of PD. Pan-inhibitors ...

However if you have a medical condition that affects your driving but don't voluntarily give up your licence, you must inform the DVLA, which will decide if you can continue holding a driving licence.

On Thursday, Jan. 30, the "Walking in Memphis" hitmaker posted about his Parkinson's disease diagnosis on Instagram and explained why he is sharing the news years later. "I feel like it's time to ...

A word. A sentence. A fate. Mine? Parkinson’s, the P word. It arises unbidden as I walk, my left leg not quite keeping pace with my right. It floats to top of mind when my tremor flares in a ...

These transgenic mice overexpress human tau, specifically the 4R/2N isoform, bearing the P301L mutation under the control of the neuron-specific murine Thy1 promoter (Terwel et al., 2005). The ...

As an iron chaperone, it has excellent potential to treat Parkinson's disease as well as various Parkinsonian ... the support cells of the central nervous system, and neuron loss in multiple brain ...